Publications
5530 Results
- Journal / Conference
- JNCI 82:1353-1354
- Year
- 1990
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8323
Activity of fludarabine monophosphate in patients with Lymphoma advanced mycosis fungoides: A Southwest Oncology Group study.
- Journal / Conference
- JCO 13(5):433-435
- Year
- 1990
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8328
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced cervical cancer. A Southwest Oncology Group study.
- Journal / Conference
- Invest New Drugs 8:S87-S89
- Year
- 1990
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8373
Phase II trial of intravenous melphalan for metastatic colorectal carcinoma: A Southwest Oncology Group study.
- Journal / Conference
- Invest New Drugs 8:81-85
- Year
- 1990
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8404
Phase II evaluation of esorubicin (4' deoxydoxorubicin) in pancreatic adenocarcinoma. A Southwest Oncology Group study.
- Journal / Conference
- Obst and Gyn 75(4):696-700
- Year
- 1990
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8407
Carboplatin therapy in advanced endometrial cancer. A Southwest Oncology Group study.
- Journal / Conference
- IND 8:199-200
- Year
- 1990
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8409
Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study.
- Journal / Conference
- JCO 8(7):1155-1162
- Year
- 1990
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8410
M-BACOD treatment for intermediate and high grade malignant lymphomas: A Southwest Oncology Group phase II trial.
- Journal / Conference
- Carboplatin Current Perspectives and Future Directions (JM-8):163-164
- Year
- 1990
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8412
Improved efficacy of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Preliminary report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV suboptimal ovarian cancer.
- Journal / Conference
- Invest New Drugs 8:93-95
- Year
- 1990
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8426
VM-26 in colorectal carcinoma: A Southwest Oncology Group study.
- Journal / Conference
- Cancer 65:866-869
- Year
- 1990
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8465